However, the presence of GLP-1 receptor in human hepatocytes is controversial and the mechanisms by which GLP-1 analogues act directly on liver, reducing hepatic steatosis, inflammation and fibrosis remain to be established [66,69]. Here, GLP1R is linked to fatty liver disease.